Chongqing, China, March 27, 2020--Today, Porton Pharma Solutions Ltd. released its 2019 Annual Report.
After more than two years of CDMO business transformation, 2019 proved to be a year for regaining growth in both commercial and financial performance for Porton. Prioritizing technology and service in our development strategy ensures the fulfillment of our business plan. Our business achieved robust growth and we have continued to attract and maintain leading talent.
The following pictures will help you have a quick look at our performance in 2019.
